mTOR Antibodies

Santa Cruz Biotechnology features a diverse variety of mTOR Antibodies for research focused on understanding the mechanistic target of rapamycin (mTOR) signaling pathways. mTOR Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). mTOR is a central regulator of cell growth, proliferation, and survival, playing a pivotal role in cellular responses to nutrients, growth factors, and stress. Dysregulation of mTOR signaling is implicated in numerous diseases, including cancer, metabolic disorders, and neurodegenerative conditions, making mTOR a significant target for therapeutic intervention. Understanding mTOR's function and pathways can provide insights into potential treatment strategies and the development of novel drugs. Researchers worldwide utilize mTOR monoclonal antibodies to investigate cellular signaling mechanisms and disease pathways. Advanced research techniques incorporating mTOR monoclonal antibodies help unlock new discoveries in cell biology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific understanding of mTOR pathways.